Basic information Safety Supplier Related

Letolizumab

Basic information Safety Supplier Related

Letolizumab Basic information

Product Name:
Letolizumab
Synonyms:
  • Letolizumab
  • Research Grade Letolizumab (DHD85401)
  • Research Grade Letolizumab
  • Letolizumab (anti-TNFSF5)
CAS:
1450981-87-9
MW:
0
Mol File:
Mol File
More
Less

Letolizumab Chemical Properties

form 
Liquid
color 
Colorless to light yellow
More
Less

Letolizumab Usage And Synthesis

Uses

Letolizumab (BMS-986004) is a monoclonal antibody targeting CD40L, which is produced to express mutant IgG1 lacking effector function, including Fc binding and complement fixation. Letolizumab reduces rejection, thromboembolism and prolongs the survival time[1][2][3].

in vivo

Letolizumab inhibits the viability of CD40L trimer and CHO-CD40L in human B cell (IC50 values of 3.6 nM and 1.3 nM, respectively) or nonhuman primate B cell (IC50 values of 3.8 nM and 7.3 nM, respectively)[2].
Letolizumab (2, 10 and 20 mg/kg; i.v.; once a week for 10 weeks) prolongs the survival time of rhesus macaques after renal transplantation[2].

Animal Model:Rhesus macaques after renal transplantation[2].
Dosage:2, 10 and 20 mg/kg.
Administration:Intravenous injection; once a week for 10 weeks.
Result:Increased the survival time.

IC 50

CD40L

References

[1] Karnell JL, et al. Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond. Adv Drug Deliv Rev. 2019 Feb 15;141:92-103. DOI:10.1016/j.addr.2018.12.005
[2] Kim SC, et al. Fc-Silent Anti-CD154 Domain Antibody Effectively Prevents Nonhuman Primate Renal Allograft Rejection. Am J Transplant. 2017 May;17(5):1182-1192. DOI:10.1111/ajt.14197
[3] Spicer P, et al. Costimulatory pathway targets for autoimmune and inflammatory conditions: clinical successes, failures, and hope for the future. Expert Opin Investig Drugs. 2019 Feb;28(2):99-106. DOI:10.1080/13543784.2019.1557146

LetolizumabSupplier

Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Email
3008007409@qq.com
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Email
2853530910@QQ.com
Wuhan Chemstan Biotechnology Co., Ltd.
Tel
027-65317797 15926423062
Email
422450190@qq.com
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com
Biolab Reagents
Tel
027-65279366 18108604356
Email
products@biolabreagent.com
More
Less